however, is that it is highly inappropriate to simply assume clinical equivalence between competing therapies as a justification for the use of cost-minimisation analysis.
however, is that it is highlyinappropriate to simply assume clinicalequivalence between competing therapies as ajustification for the use of cost-minimisationanalysis.